Amplification and protein expression of androgen receptor gene in prostate cancer cells: Fluorescence in situ hybridization analysis

Zhang,Xian; Hong,Shi‑Zhe; Lin,Er‑Jiang; Wang,Da‑Ya; Li,Zhi‑Jia; Chen,Li

doi:10.3892/ol.2015.3114

Amplification and protein expression of androgen receptor gene in prostate cancer cells: Fluorescence in situ hybridization analysis

Authors:
- Xian Zhang
- Shi‑Zhe Hong
- Er‑Jiang Lin
- Da‑Ya Wang
- Zhi‑Jia Li
- Li Chen
View Affiliations

Affiliations: Department of Urology, Wenzhou Central Hospital, Wenzhou, Zhejiang 325000, P.R. China
Published online on: April 14, 2015 https://doi.org/10.3892/ol.2015.3114
Pages: 2617-2622

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate cancer (PCa) is the most frequently diagnosed non-skin cancer and the second highest cause of cancer-related mortality in adult males worldwide. PCa is highly dependent upon androgen receptor (AR) signaling for cell proliferation and survival. The AR therefore plays a vital role in the development and function of normal and malignant prostate cells or PCa recurrence. The present study aimed to examine the ubiquity of AR amplification in PCa recurrence, even in the absence of androgen. For this purpose, specimens were collected from 37 patients. The amplification of AR and the number of X chromosomes were determined by two‑colored fluorescence in situ hybridization analysis. The automated image analysis was used to determine the protein expression of AR. Clinical characteristics and survival in patients whose tumors showed or did not show AR amplification and in X‑chromosome polysomy with PCa recurrence has also been compared. The results showed that >35% of patients (13 specimens) exhibited AR amplification. It was also observed that AR was immunostained more intensely in the tumors with amplified AR compared with those tumors with non‑amplified AR. This study demonstrated an influential role of AR in tumor growth and progression even after the deprivation of androgen, as well as showing the potential contribution of AR amplification to AR activation even in the relative absence of androgen.

View Figures

View References

1	Lassi K and Dawson NA: Update on castrate-resistant prostate cancer: 2010. Curr Opin Oncol. 22:263–267. 2010. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
3	Shahrokh F, Shariat, Axel S, et al: Tumor markers in prostate cancer I: Blood-based markers. Acta Oncol. 50:61–75. 2011. View Article : Google Scholar
4	Culig Z, Hobisch A, Bartsch G and Klocker H: Androgen receptor - an update of mechanisms of action in prostate cancer. Urol Res. 28:211–219. 2000. View Article : Google Scholar : PubMed/NCBI
5	Visakorpi T, Hyytinen E, Koivisto P, et al: In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet. 9:401–406. 1995. View Article : Google Scholar : PubMed/NCBI
6	Cude KJ, Montgomery JS, Price DK, et al: The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer. Urol Int. 68:16–23. 2002. View Article : Google Scholar : PubMed/NCBI
7	Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev. 25:276–308. 2004. View Article : Google Scholar : PubMed/NCBI
8	Chen CD, Welsbie DS, Tran C, et al: Molecular determinants of resistance to antiandrogen therapy. Nat Med. 10:33–39. 2004. View Article : Google Scholar : PubMed/NCBI
9	Gelmann EP: Molecular biology of the androgen receptor. J Clin Oncol. 20:3001–3015. 2002. View Article : Google Scholar : PubMed/NCBI
10	Shaffer DR and Scher HI: Prostate cancer: a dynamic illness with shifting targets. Lancet Oncol. 4:407–414. 2003. View Article : Google Scholar : PubMed/NCBI
11	Linja MJ and Visakorpi T: Alterations of androgen receptor in prostate cancer. J Steroid Biochem Mol Biol. 92:255–264. 2004. View Article : Google Scholar : PubMed/NCBI
12	Kiessling A, Hogrefe C, Erb S, et al: Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene. 28:2606–2620. 2009. View Article : Google Scholar : PubMed/NCBI
13	Bubendorf L, Kononen J, Koivisto P, et al: Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 59:803–806. 1999.PubMed/NCBI
14	Edwards J, Krishna NS, Mukherjee R, Watters AD, Underwood MA and Bartlett JM: Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer. BJU Int. 88:633–637. 2001. View Article : Google Scholar : PubMed/NCBI
15	Koivisto P, Hyytinen E, Palmberg C, et al: Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy. Am J Pathol. 147:1608–1614. 1995.PubMed/NCBI
16	Feldman BJ and Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer. 1:34–45. 2001. View Article : Google Scholar : PubMed/NCBI
17	Hyytinen ER, Haapala K, Thompson J, et al: Pattern of somatic androgen receptor gene mutations in patients with hormone-bractory prostate cancer. Lab Invest. 82:1591–1598. 2002. View Article : Google Scholar : PubMed/NCBI
18	Koivisto P, Kononen J, Palmberg C, et al: Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 57:314–319. 1997.PubMed/NCBI
19	Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL and Visakorpi T: Amplification and overexpression of androgen receptor gene in hormone-bractory prostate cancer. Cancer Res. 61:3550–3555. 2001.PubMed/NCBI
20	Leversha MA, Han J, Asgari Z, et al: Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res. 15:2091–2097. 2009. View Article : Google Scholar : PubMed/NCBI
21	Brown RS, Edwards J, Dogan A, et al: Amplification of the androgen receptor gene in bone metastases from hormone-bractory prostate cancer. J Pathol. 198:237–244. 2002. View Article : Google Scholar : PubMed/NCBI